Conformational mAb as a tool for integrin ligand discovery

Assay and Drug Development Technologies

Volumn 7, Issue 5, 2009, Pages 507-515

  Njus, Ben H ^a   Chigaev, Alexandre ^b   Waller, Anna ^b   Wlodek, Danuta ^b   Ostopovici Halip, Liliana ^a,c   Ursu, Oleg ^a   Wang, Wei ^a   Oprea, Tudor I ^a   Bologa, Cristian G ^a   Sklar, Larry A ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c ACADEMY OF ROMANIAN SCIENTISTS   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HUTS 21; N (2,6 DICHLOROBENZOYL) LEVO 4 (2',6' BIS METHOXYPHENYL)PHENYLALANINE; PHENYLALANINE DERIVATIVE; TR 14035; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; BINDING SITE; CELL STRAIN U937; CONFORMATIONAL TRANSITION; DRUG BINDING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOLECULAR DOCKING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD29; BINDING, COMPETITIVE; EPITOPES; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; INTEGRINS; KINETICS; LIGANDS; PROTEIN CONFORMATION; U937 CELLS;

EID: 70450286210     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2009.0203     Document Type: Article

References (30)

1. Alghisi GC, Ruegg C: Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Endothelium 2006;13:113-135.
2. Tucker GC: Integrins: molecular targets in cancer therapy. Curr Oncol Rep 2006;8:96-103.
3. Vanderslice P, Woodside DG: Integrin antagonists as therapeutics for infl ammatory diseases. Expert Opin Investig Drugs 2006;15:1235-1255.
4. Woodside DG, Vanderslice P: Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease. BioDrugs 2008;22:85-100.
5. Arnaout MA, Goodman SL, Xiong JP: Structure and mechanics of integrinbased cell adhesion. Curr Opin Cell Biol 2007;19:495-507.
6. Chigaev A, Waller A, Zwartz GJ, Buranda T, Sklar LA: Regulation of cell adhesion by affi nity and conformational unbending of alpha4beta1 integrin. J Immunol 2007;178:6828-6839.
7. Larson RS, Davis T, Bologa C, Semenuk G, Vijayan S, Li Y, et al.: Dissociation of I domain and global conformational changes in LFA-1: refi nement of small molecule- I domain structure-activity relationships. Biochemistry 2005;44: 4322-4331.
8. Frelinger AL, III, Cohen I, Plow EF, Smith MA, Roberts J, Lam SC, et al.: Selective inhibition of integrin function by antibodies specifi c for ligand-occupied receptor conformers. J Biol Chem 1990;265:6346-6352.
9. Mould AP, Barton SJ, Askari JA, McEwan PA, Buckley PA, Craig SE, et al.: Conformational changes in the integrin beta A domain provide a mechanism for signal transduction via hybrid domain movement. J Biol Chem 2003;278:17028- 17035.
10. Mould AP, Travis MA, Barton SJ, Hamilton JA, Askari JA, Craig SE, et al.: Evidence that monoclonal antibodies directed against the integrin beta subunit plexin/ semaphorin/integrin domain stimulate function by inducing receptor extension. J Biol Chem 2005;280:4238-4246.
11. Jackson DY: Alpha 4 integrin antagonists. Curr Pharm Des 2002;8:1229-1253.
12. Sklar LA, Carter MB, Edwards BS: Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening. Curr Opin Pharmacol 2007;7:527-534.
13. Chigaev A, Blenc AM, Braaten JV, Kumaraswamy N, Kepley CL, Andrews RP, et al.: Real time analysis of the affi nity regulation of alpha 4-integrin. The physiologically activated receptor is intermediate in affi nity between resting and Mn(2+) or antibody activation. J Biol Chem 2001;276:48670-48678.
14. Chigaev A, Zwartz G, Graves SW, Dwyer DC, Tsuji H, Foutz TD, Edwards BS, et al.: Alpha4beta1 integrin affi nity changes govern cell adhesion. J Biol Chem 2003;278:38174-38182.
15. Chigaev A, Buranda T, Dwyer DC, Prossnitz ER, Sklar LA: FRET detection of cellular alpha4-integrin conformational activation. Biophys J 2003;85:3951-3962.
16. Egger LA, Kidambi U, Cao J, Van Riper G, McCauley E, Mumford RA, et al.: Alpha(4) beta(7)/alpha(4)beta(1) dual integrin antagonists block alpha(4)beta(7)-dependent adhesion under shear flow. J Pharmacol Exp Ther 2002;302:153-162.
17. Arnold K, Bordoli L, Kopp J, Schwede T: The SWISS-MODEL workspace: a webbased environment for protein structure homology modelling. Bioinformatics 2006;22:195-201.
18. Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997;18:2714-2723.
19. Schwede T, Kopp J, Guex N, Peitsch MC: SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 2003;31:3381-3385.
20. Notredame C, Higgins DG, Heringa J: T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 2000;302:205-217.
21. Poirot O, O'Toole E, Notredame C: Tcoffee@igs: A web server for computing, evaluating and combining multiple sequence alignments. Nucleic Acids Res 2003;31:3503-3506.
22. Chigaev A, Waller A, Amit O, Sklar LA: GalphaS-coupled receptor signaling actively down-regulates alpha4beta1-integrin affi nity: a possible mechanism for cell de-adhesion. BMC Immunol 2008;9:26.
23. Hyduk SJ, Chan JR, Duffy ST, Chen M, Peterson MD, Waddell TK, et al.: Phospholipase C, calcium, and calmodulin are critical for alpha4beta1 integrin affi nity up-regulation and monocyte arrest triggered by chemoattractants. Blood 2007;109:176-184.
24. Gong Y, Barbay JK, Dyatkin AB, Miskowski TA, Kimball ES, Prouty SM, et al.: Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists. J Med Chem 2006;49:3402-3411.
25. Lin K, Ateeq HS, Hsiung SH, Chong LT, Zimmerman CN, Castro A, et al.: Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses. J Med Chem 1999;42:920-934.
26. Chigaev A, Waller A, Amit O, Halip L, Bologa CG, Sklar LA: Realtime analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation. J Biol Chem 2009;284:14337-14346.
27. Lapidot T, Petit I: Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30:973-981.
28. Lapidot T, Dar A, Kollet O: How do stem cells fi nd their way home?. Blood 2005;106:1901-1910.
29. Hernandez-Hansen V, Smith AJ, Surviladze Z, Chigaev A, Mazel T, Kalesnikoff J, Lowell CA, et al.: Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-defi cient mast cells. J Immunol 2004;173:100-112.
30. Humphries JD, Byron A, Humphries MJ: Integrin ligands at a glance. J Cell Sci 2006;119:3901-3903.